Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study - PubMed (original) (raw)
doi: 10.1136/jnnp.2010.235952. Epub 2011 Mar 14.
Collaborators, Affiliations
- PMID: 21402743
- DOI: 10.1136/jnnp.2010.235952
Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study
Adriano Chiò et al. J Neurol Neurosurg Psychiatry. 2011 Jul.
Abstract
Background: Different amyotrophic lateral sclerosis (ALS) phenotypes have been recognised, marked by a varying involvement of spinal and bulbar upper and lower motor neurons. However, the differential characteristics of these phenotypes are still largely unknown.
Objective: To define the epidemiology and outcome of ALS phenotypes in a population based setting.
Methods: All ALS cases incident in two Italian regions were prospectively collected from 1995 to 2004 in an epidemiological register. Cases were classified according to established ALS phenotypes: classic, bulbar, flail arm, flail leg, pyramidal, respiratory, pure lower motor neuron (PLMN) and pure upper motor neuron (PUMN).
Results: ALS phenotype were determined in 1332 out of 1351 incident patients (98.6%). Classic and bulbar phenotypes had similar mean annual incidence rates. Gender specific incidence rates showed a male preponderance in respiratory, flail arm, classic and PLMN phenotypes; in all other phenotypes, men and women had similar incidence rates. Age at onset was significantly lower in pyramidal, PLMN and PUMN phenotypes and higher in the bulbar phenotype. The best outcomes were observed in PUMN, pyramidal, PLMN and flail arm phenotypes and the worst in respiratory and bulbar phenotypes.
Conclusions: Our epidemiological findings suggest that ALS phenotypes carry distinctive and easily distinguishable clinical and prognostic characteristics, strongly related to a complex interplay between gender and age. The categorisation of ALS patients according to more homogenous clinical groups is relevant in identifying biological markers for ALS and should be considered for the design of clinical trials.
Comment in
- ALS: disease or syndrome?
van den Berg LH. van den Berg LH. J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):711. doi: 10.1136/jnnp.2011.241513. Epub 2011 Apr 2. J Neurol Neurosurg Psychiatry. 2011. PMID: 21460388 No abstract available.
Similar articles
- Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis - data from a population-based registry.
Wolf J, Safer A, Wöhrle JC, Palm F, Nix WA, Maschke M, Grau AJ. Wolf J, et al. J Neurol Sci. 2014 Oct 15;345(1-2):164-7. doi: 10.1016/j.jns.2014.07.033. Epub 2014 Jul 19. J Neurol Sci. 2014. PMID: 25086855 - ALS phenotype is influenced by age, sex, and genetics: A population-based study.
Chiò A, Moglia C, Canosa A, Manera U, D'Ovidio F, Vasta R, Grassano M, Brunetti M, Barberis M, Corrado L, D'Alfonso S, Iazzolino B, Peotta L, Sarnelli MF, Solara V, Zucchetti JP, De Marchi F, Mazzini L, Mora G, Calvo A. Chiò A, et al. Neurology. 2020 Feb 25;94(8):e802-e810. doi: 10.1212/WNL.0000000000008869. Epub 2020 Jan 6. Neurology. 2020. PMID: 31907290 - Longitudinal respiratory trajectories in motor neuron disease phenotypes: Multiparametric characterization and clinical management.
Ferraro PM, Mollar E, Melissari L, Buscema M, Bagnoli E, Cabona C, Gemelli C, Vignolo M, Maranzana C, Marogna M, Ferrera L, Beronio A, De Michelis C, Bergamaschi V, Bragadin MM, Brichetto G, Braido F, Rao F. Ferraro PM, et al. Respir Med. 2025 Apr;239:108003. doi: 10.1016/j.rmed.2025.108003. Epub 2025 Feb 15. Respir Med. 2025. PMID: 39961396 - Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis).
Jawdat O, Statland JM, Barohn RJ, Katz JS, Dimachkie MM. Jawdat O, et al. Neurol Clin. 2015 Nov;33(4):775-85. doi: 10.1016/j.ncl.2015.07.003. Epub 2015 Sep 8. Neurol Clin. 2015. PMID: 26515621 Free PMC article. Review. - Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS).
Grad LI, Rouleau GA, Ravits J, Cashman NR. Grad LI, et al. Cold Spring Harb Perspect Med. 2017 Aug 1;7(8):a024117. doi: 10.1101/cshperspect.a024117. Cold Spring Harb Perspect Med. 2017. PMID: 28003278 Free PMC article. Review.
Cited by
- Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis.
Devine MS, Pannek K, Coulthard A, McCombe PA, Rose SE, Henderson RD. Devine MS, et al. Neuroimage Clin. 2015 Mar 14;7:782-7. doi: 10.1016/j.nicl.2015.03.006. eCollection 2015. Neuroimage Clin. 2015. PMID: 25844330 Free PMC article. - Endogenous female reproductive hormones and the risk of amyotrophic lateral sclerosis.
de Jong S, Huisman M, Sutedja N, van der Kooi A, de Visser M, Schelhaas J, van der Schouw Y, Veldink J, van den Berg L. de Jong S, et al. J Neurol. 2013 Feb;260(2):507-12. doi: 10.1007/s00415-012-6665-5. Epub 2012 Sep 13. J Neurol. 2013. PMID: 22972621 - Diagnostic and Prognostic Value of Conventional Brain MRI in the Clinical Work-Up of Patients with Amyotrophic Lateral Sclerosis.
Rizzo G, Marliani AF, Battaglia S, Albini Riccioli L, De Pasqua S, Vacchiano V, Infante R, Avoni P, Donadio V, Passaretti M, Bartolomei I, Salvi F, Liguori R, On Behalf Of The BoReALS Group. Rizzo G, et al. J Clin Med. 2020 Aug 6;9(8):2538. doi: 10.3390/jcm9082538. J Clin Med. 2020. PMID: 32781557 Free PMC article. - Motoneuron Diseases.
Lotti F, Przedborski S. Lotti F, et al. Adv Neurobiol. 2022;28:323-352. doi: 10.1007/978-3-031-07167-6_13. Adv Neurobiol. 2022. PMID: 36066831 - Microstructural changes across different clinical milestones of disease in amyotrophic lateral sclerosis.
Trojsi F, Caiazzo G, Corbo D, Piccirillo G, Cristillo V, Femiano C, Ferrantino T, Cirillo M, Monsurrò MR, Esposito F, Tedeschi G. Trojsi F, et al. PLoS One. 2015 Mar 20;10(3):e0119045. doi: 10.1371/journal.pone.0119045. eCollection 2015. PLoS One. 2015. PMID: 25793718 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous